CLINICAL_TRIALS
trial_result
· 2018-10-23
Clinical Trial Update: Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA [Phase 3]
Summary
Phase 3 trial onabotulinumtoxinA for chronic post-traumatic headache was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Chronic Post Traumatic Headache | Phase 3 | Status: TERMINATED | Results posted: 2018-10-23